Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 268

Similar articles for PubMed (Select 8896785)

1.

Treatment of bipolar depression with carbamazepine: results of an open study.

Dilsaver SC, Swann SC, Chen YW, Shoaib A, Joe B, Krajewski KJ, Gruber N, Tsai Y.

Biol Psychiatry. 1996 Nov 1;40(9):935-7. No abstract available.

PMID:
8896785
2.
3.

Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial.

Weisler RH, Keck PE Jr, Swann AC, Cutler AJ, Ketter TA, Kalali AH; SPD417 Study Group.

J Clin Psychiatry. 2005 Mar;66(3):323-30. Erratum in: J Clin Psychiatry. 2005 May;66(5):659.

PMID:
15766298
4.

Pharmacotherapy of inpatients with bipolar depression.

Howland RH.

Ann Clin Psychiatry. 1997 Dec;9(4):199-202.

PMID:
9511942
5.

Bipolar switching after carbamazepine withdrawal.

Lange-Asschenfeldt C, Blaeser I, Supprian T.

Pharmacopsychiatry. 2007 Mar;40(2):86-7. No abstract available.

PMID:
17447183
6.

Is bipolar disorder still underdiagnosed? Are antidepressants overutilized?

Ghaemi SN, Sachs GS, Chiou AM, Pandurangi AK, Goodwin K.

J Affect Disord. 1999 Jan-Mar;52(1-3):135-44.

PMID:
10357026
7.

The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.

Lee JH, Dunner DL.

Depress Anxiety. 2008;25(2):91-7.

PMID:
17311265
9.

An open-label trial of adjunctive oxcarbazepine for bipolar disorder.

Conway CR, Chibnall JT, Nelson LA, McGuire JM, Abraham PF, Baram VY, Grossberg GT, Carroll BJ.

J Clin Psychopharmacol. 2006 Feb;26(1):95-7. No abstract available.

PMID:
16415718
10.

Efficacy and safety of oxcarbazepine in bipolar disorder.

Mazza M, Bria P, Mazza S.

Can J Psychiatry. 2007 Apr;52(4):272; author reply 272-3. No abstract available.

PMID:
17500309
11.

Treatment of rapid-cycling bipolar disorder.

Post RM, Chang KD, Suppes T.

CNS Spectr. 2004 Feb;9(2):1-11. No abstract available.

PMID:
15032235
12.

Combined antidepressant treatment: a risk factor for switching in bipolar patients.

Gabbay V, O'Dowd MA, Asnis GM.

J Clin Psychiatry. 2002 Apr;63(4):367; author reply 367-8. No abstract available.

PMID:
12000212
13.
15.

Adverse event load in bipolar participants receiving either carbamazepine immediate-release or extended-release capsules: a blinded, randomized study.

El-Mallakh RS, Salem MR, Chopra AS, Mickus GJ, Penagaluri P.

Int Clin Psychopharmacol. 2009 May;24(3):145-9. doi: 10.1097/YIC.0b013e328329b199.

PMID:
19367153
16.

Treatment of bipolar depression.

Dubovsky SL.

Psychiatr Clin North Am. 2005 Jun;28(2):349-70, vii. Review.

PMID:
15826736
17.

On being bipolar without being bipolar.

Goldberg J.

J Psychopharmacol. 2008 Jun;22(4):402-3; discussion 408. doi: 10.1177/0269881108092123. No abstract available.

PMID:
18635717
18.

Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD.

Goldberg JF, Brooks JO 3rd, Kurita K, Hoblyn JC, Ghaemi SN, Perlis RH, Miklowitz DJ, Ketter TA, Sachs GS, Thase ME.

J Clin Psychiatry. 2009 Feb;70(2):155-62. Epub 2009 Feb 10.

PMID:
19210946
19.

Oxcarbazepine in a carbamazepine-intolerant patient with bipolar affective disorder: a case report.

Kalra H, Dalal PK, Allet L, Janca A.

Psychiatr Danub. 2006 Jun;18(1-2):90-1. No abstract available.

PMID:
16804505
20.

Comparison of early- and late-onset rapid cycling affective disorders: clinical course and response to pharmacotherapy.

Fujiwara Y, Honda T, Tanaka Y, Aoki S, Kuroda S.

J Clin Psychopharmacol. 1998 Aug;18(4):282-8.

PMID:
9690693
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk